BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 19037086)

  • 1. Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.
    Michielsen P; Heinemann L; Mihatsch M; Schnülle P; Graf H; Koch KM
    Nephrol Dial Transplant; 2009 Apr; 24(4):1253-9. PubMed ID: 19037086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic renal failure and end-stage renal disease in northwest North Carolina. Importance of analgesic-associated nephropathy.
    Gonwa TA; Hamilton RW; Buckalew VM
    Arch Intern Med; 1981 Mar; 141(4):462-5. PubMed ID: 7212889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic use and chronic renal disease.
    Sandler DP; Smith JC; Weinberg CR; Buckalew VM; Dennis VW; Blythe WB; Burgess WP
    N Engl J Med; 1989 May; 320(19):1238-43. PubMed ID: 2651928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic study of regular analgesic use and end-stage renal disease.
    Murray TG; Stolley PD; Anthony JC; Schinnar R; Hepler-Smith E; Jeffreys JL
    Arch Intern Med; 1983 Sep; 143(9):1687-93. PubMed ID: 6615090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is phenacetin responsible for analgesic nephropathy in New South Wales?
    McCredie M; Stewart JH; Mahony JF
    Clin Nephrol; 1982 Mar; 17(3):134-40. PubMed ID: 7067175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of terminal analgesics-induced nephropathy].
    Schwarz A; Pommer W; Kühn-Freitag G; Keller F; Molzahn M; Offermann G
    Schweiz Med Wochenschr; 1985 Jun; 115(23):790-5. PubMed ID: 3875149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic nephropathy: an important cause of chronic renal failure.
    Cove-Smith JR; Knapp MS
    Q J Med; 1978 Jan; 47(185):49-69. PubMed ID: 674550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure.
    McCredie M; Stewart JH; Mathew TH; Disney AP; Ford JM
    Clin Nephrol; 1989 Jan; 31(1):35-9. PubMed ID: 2783667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obituary to analgesic nephropathy--an autopsy study.
    Mihatsch MJ; Khanlari B; Brunner FP
    Nephrol Dial Transplant; 2006 Nov; 21(11):3139-45. PubMed ID: 16891638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesics use and ESRD in younger age: a case-control study.
    van der Woude FJ; Heinemann LA; Graf H; Lewis M; Moehner S; Assmann A; Kühl-Habich D
    BMC Nephrol; 2007 Dec; 8():15. PubMed ID: 18053232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining incidence of analgesic nephropathy in Canada.
    Wilson DR; Gault MH
    Can Med Assoc J; 1982 Sep; 127(6):500-2. PubMed ID: 7116267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic use and the risk for progression of chronic kidney disease.
    Kuo HW; Tsai SS; Tiao MM; Liu YC; Lee IM; Yang CY
    Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):745-51. PubMed ID: 20582905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence.
    Buckalew VM; Schey HM
    Medicine (Baltimore); 1986 Sep; 65(5):291-303. PubMed ID: 3489155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnosis of analgesic nephropathy].
    Thieler H; Schäfer W
    Z Gesamte Inn Med; 1988 Sep; 43(17):499-504. PubMed ID: 3239117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: results of the Belgian study.
    Elseviers MM; Bosteels V; Cambier P; De Paepe M; Godon JP; Lins R; Lornoy W; Matthys E; Moeremans C; Roose R
    Nephrol Dial Transplant; 1992; 7(6):479-86. PubMed ID: 1320226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephropathy as a hazard of analgesic abuse.
    Anandan JV; Matzke GR
    Am J Hosp Pharm; 1981 Oct; 38(10):1536-9. PubMed ID: 7294057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study. Analgesic Nephropathy Network of Europe.
    Elseviers MM; Waller I; Nenoy D; Levora J; Matousovic K; Tanquerel T; Pommer W; Schwarz A; Keller E; Thieler H
    Nephrol Dial Transplant; 1995; 10(6):808-14. PubMed ID: 7566608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the nephrotoxicity of analgesics.
    Gault MH
    Can Med Assoc J; 1972 Oct; 107(8):756-8. PubMed ID: 4638851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee.
    Brunner FP; Selwood NH
    Nephrol Dial Transplant; 1994; 9(10):1371-6. PubMed ID: 7816247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures.
    Elseviers MM; De Broe ME
    Nephrol Dial Transplant; 1994; 9(1):41-6. PubMed ID: 8177475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.